Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer: A Single-center Prospective Observational Study

NCT07267247 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.

NCT NCT07267247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer: A Single-center Prospective Observational Study
Lead sponsor
Taichung Veterans General Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2022
Completion date
April 30, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, drug-related side effects and adverse reactions (mesh term), egfr tyrosine kinase inhibitor, non-small cell lung cancer (mesh term: carcinoma, non-small-cell lung)